文献速递心血管技术与安全CTDSAPET

全国冠状动脉疾病影像检查趋势:与医疗结局和费用的关联

National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-01-11

该研究从全国数据库提取2012至2018年冠状动脉疾病检查数据,分析影像使用趋势及CG95指南影响。共1,909,314次检查,年人均增长4.8%;CG95与CCTA增长相关(exp[β]:1.10;95% CI:1.03-1.18),CCTA增长与心血管死亡率降低相关(Kendall Tau:-0.21;P = 0.045)。

要点

  • 2012至2018年冠状动脉疾病影像检查年人均增长4.8%,费用为每年每10万人口35万英镑。
  • CG95指南发布与CCTA使用增加相关(exp[β]:1.10;95% CI:1.03-1.18)。
  • 区域CCTA增长与心血管死亡率降低相关(Kendall Tau:-0.21;P = 0.045)。

核心结论

  • 冠状动脉疾病影像检查量在增加;区域CCTA增长幅度较大与心肌梗死住院减少及CAD死亡率更快速下降相关。

研究设计与样本

  • 从全国数据库提取2012至2018年检查数据,并与医院入院和死亡登记链接;采用Kendall秩相关比较影像模式使用、心血管住院和死亡率,采用中断时间序列分析评估CG95影响。

诊断标准与关键数值

  • CG95与CCTA上升相关(exp[β]:1.10;95% CI:1.03-1.18)。
  • CG95与心肌灌注成像无变化相关。
  • CG95与有创冠状动脉造影可能轻度下降相关(exp[β]:0.997;95% CI:0.993-1.00)。
  • CCTA增长与心血管死亡率降低相关(Kendall Tau:-0.21;P = 0.045),与缺血性心脏病死亡降低相关(Kendall Tau:-0.22;P = 0.042)。
  • CCTA增长与全因死亡率降低呈 apparent trend(Kendall Tau:-0.19;P = 0.07)。

局限性

  • 区域CCTA增长与有创导管造影减少之间仅为 apparent trend(Kendall Tau:-0.19;P = 0.08)。
  • CCTA增长与全因死亡率降低之间仅为 apparent trend(Kendall Tau:-0.19;P = 0.07)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: In 2016, the National Institute for Health and Care Excellence Clinical Guideline Number 95 ("Chest pain of recent onset") (CG95) recommended coronary computed tomography angiography (CCTA) as the first-line test for possible angina.

OBJECTIVES: The purpose of this study was to determine the impact of temporal trends in imaging use on outcomes for coronary artery disease (CAD) following the CG95 recommendations.

METHODS: Investigations from 2012 to 2018 were extracted from a national database and linked to hospital admission and mortality registries. Growth rates were adjusted for population size, with image modality use, cardiovascular hospital admissions, and mortality compared using Kendall's rank correlation. The impact of CG95 was assessed using an interrupted time-series analysis.

RESULTS: A total of 1,909,314 investigations for CAD were performed, with an annualized per capita growth of 4.8%. Costs were £0.35 million/100,000 population/year with an increase of 2.8%/year mirroring inflation (2.5%/year). CG95 was associated with a rise in CCTA (exp[β]: 1.10; 95% CI: 1.03-1.18), no change in myocardial perfusion imaging, and a potential modest fall (exp[β]: 0.997; 95% CI: 0.993-1.00]) in invasive coronary angiography. There was an apparent trend between computed tomography angiography growth and invasive catheter angiography reduction across regions (Kendall Tau: -0.19; P = 0.08). CCTA growth was associated with a reduction in cardiovascular mortality (Kendall Tau: -0.21; P = 0.045), and ischemic heart disease deaths (Kendall Tau: -0.22; P = 0.042), with an apparent trend with reduced all-cause mortality (Kendall Tau: -0.19; P = 0.07).

CONCLUSIONS: Imaging investigations for CAD are increasing. Greater regional increases in CCTA were associated with fewer hospitalizations for myocardial infarction and a more rapid decline in CAD mortality.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Weir-McCall JR, Williams MC, Shah ASV, et al. National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs. JACC Cardiovasc Imaging. 2023. PMID: 36752441. doi:10.1016/j.jcmg.2022.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。